Literature DB >> 236738

Septic lung and shock lung in man.

G H Clowes, E Hirsch, L Williams, E Kwasnik, T F O'Donnell, P Cuevas, V K Saini, I Moradi, M Farizan, C Saravis.   

Abstract

Two series of patients were studied by serial measurements of blood gas exchange and pulmonarmonary dysfunction and to evaluate the dangers of respiratory failure in post traumatic patients. There were 27 patients who had sustained profound hemorrhagic shock and massive blood replacement averaging 9.7 liters and 38 patients who suffered general peritonitis or other forms of fulminating nonthoracic sepsis. All were supported by endotrachael intubation and volume controlled ventilators. The overall mortality for the post shock patients without sepsis was 12% while in the septic patients it was 35%. The maximal pulmonary arteriovenous shunt encountered in the post hemorrhagic shock patients at 36 hours averaged 20 plus or minus 8% and was accompanied by high cardiac indices (average 5.1 plus or minus 1.3 L/M-2/min) but no significant rise of pulmonary arterial pressure or peak inspiratory pressure (PIP). Severe pulmonary dysfunction subsequently occurred only in those patients who later became septic. The studies on the septic patients were divided according to the magnitude of the cardiac indices (the high indices averaged 4.8 plus or minus 1.6L/M-2/min) and thelow indices averaged 1.9 plus or minus 1.0 L/M-2/min. In the former, the average maximal shunt of 30 plus or minus 6% was sustained for 4 or more days, accompanied by an elevation of PIP to 36 plus or minus 6 cm H2O and by Pa pressure of 28 plus or minus 5 mm Hg. The patients in low output septic shock usually had an associated bronchopneumonia and had an average venous admixture of 34 plus or minus 8% and PIP values of 41 plus or minus 8 cm H2O. The mean Pa pressure in this group was 29 plus or minus 6 mm Hg.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 236738      PMCID: PMC1345566          DOI: 10.1097/00000658-197505000-00024

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

1.  HIGH OUTPUT RESPIRATORY FAILURE: AN IMPORTANT CAUSE OF DEATH ASCRIBED TO PERITONITIS OR ILEUS.

Authors:  J F BURKE; H PONTOPPIDAN; C E WELCH
Journal:  Ann Surg       Date:  1963-10       Impact factor: 12.969

2.  Influence of perfusate characteristics on pulmonary vascular response to endotoxin.

Authors:  L B HINSHAW; H KUIDA; R P GILBERT; M B VISSCHER
Journal:  Am J Physiol       Date:  1957-11

3.  Effect of gram-negative endotoxin on pulmonary circulation.

Authors:  H KUIDA; L B HINSHAW; R P GILBERT; M B VISSCHER
Journal:  Am J Physiol       Date:  1958-02

4.  The pathology of secondary shock.

Authors:  V H MOON
Journal:  Am J Pathol       Date:  1948-03       Impact factor: 4.307

Review 5.  Host defense mechanisms against infection.

Authors:  J W Alexander
Journal:  Surg Clin North Am       Date:  1972-12       Impact factor: 2.741

6.  Physiologic consequences of positive end-expiratory pressure (PEEP) ventilation.

Authors:  S R Powers; R Mannal; M Neclerio; M English; C Marr; R Leather; H Ueda; G Williams; W Custead; R Dutton
Journal:  Ann Surg       Date:  1973-09       Impact factor: 12.969

7.  Studies of pulmonary insufficiency in non-thoracic trauma.

Authors:  S R Powers; R Burdge; R Leather; V Monaco; J Newell; S Sardar; E J Smith
Journal:  J Trauma       Date:  1972-01

8.  Energy metabolism in sepsis: treatment based on different patterns in shock and high output stage.

Authors:  G H Clowes; T F O'Donnell; N T Ryan; G L Blackburn
Journal:  Ann Surg       Date:  1974-05       Impact factor: 12.969

9.  Cerebral etiology of the "shock lung syndrome".

Authors:  G Moss; C Staunton; A A Stein
Journal:  J Trauma       Date:  1972-10

10.  Hemodynamic and respiratory changes associated with sepsis following combat trauma.

Authors:  E F Hirsch; R Fletcher; S Lucas
Journal:  Ann Surg       Date:  1971-08       Impact factor: 12.969

View more
  11 in total

1.  Severe chronic intra-abdominal sepsis: a report of 3 cases and a review of patient management.

Authors:  C H Browne; E Gross; G C Hanson; A K Webb
Journal:  Intensive Care Med       Date:  1978-04       Impact factor: 17.440

2.  Pulmonary microvascular injury induced by Pseudomonas aeruginosa cytotoxin in isolated rabbit lungs.

Authors:  W Seeger; D Walmrath; H Neuhof; F Lutz
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

3.  Cardiopulmonary effects of volume loading in patients in septic shock.

Authors:  M M Krausz; A Perel; D Eimerl; S Cotev
Journal:  Ann Surg       Date:  1977-04       Impact factor: 12.969

4.  Mechanism responsible for endotoxin-induced lung microsomal dysfunction in rats.

Authors:  N Kambara; K Takagi; T Satake; S Sugiyama; T Ozawa
Journal:  Lung       Date:  1983       Impact factor: 2.584

Review 5.  Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review.

Authors:  A L Katzenstein; C M Bloor; A A Leibow
Journal:  Am J Pathol       Date:  1976-10       Impact factor: 4.307

6.  An extreme form of the hyperdynamic syndrome in septic shock.

Authors:  J D Baumgartner; C Vaney; C Perret
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

7.  Basic life supports: community hospital management of respiratory failure.

Authors:  M T Newhouse
Journal:  Can Fam Physician       Date:  1979-10       Impact factor: 3.275

8.  Direct and indirect effects of E. coli lipopolysaccharide on isolated human polymorphonuclear granulocytes and mixed leukocytes.

Authors:  H Opdahl
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

9.  Right ventricular dysfunction in acute thermal injury.

Authors:  J A Martyn; M T Snider; S K Szyfelbein; J F Burke; M B Laver
Journal:  Ann Surg       Date:  1980-03       Impact factor: 12.969

10.  The acute effects of prostaglandin E1 on the pulmonary circulation and oxygen delivery in patients with the adult respiratory distress syndrome.

Authors:  H Tokioka; O Kobayashi; Y Ohta; T Wakabayashi; F Kosaka
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.